CAndesartan vs LIsinopril Effects on the BRain
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 176 participants.
Also called NCT01984164
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 176 participants
- Registry
-
NCT01984164
-
- Other papers using this trial's data
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01984164. Randomized; double masking; primary purpose prevention. Start 2014-08-20 (actual); primary completion 2018-12-03 (actual). Results posted on 2021-02-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CAndesartan vs LIsinopril Effects on the BRain
- Acronym
- CALIBREX
- Condition
- Hypertension
- Condition
- Mild Cognitive Impairment
- Intervention (Drug)
- Candesartan
- Intervention (Drug)
- Lisinopril
- Lead sponsor
- Emory University
- Collaborator
- National Institute on Aging (NIA)
Record details
- Record id
cardio:ct-nct01984164- Content hash
f2a8fb27a4e36283eac28c6ee30e77c4b810b7e9e72d597ee296088ef03a7151